Nuveen California Select Tax-Free Income Portfolio NXC
Set alert
At close · Jan 9
After hours · Jan 9, 4:00 PM ET
- YTD
- +0.68%
- 1 year
- +2.39%
- Open
- 13.27
- Prev close
- 13.29
- Mkt cap
- 83.60M
- Vol
- 76.96K
- Avg vol
- 19.52K
- EPS
- 0.85
- P/E
- 15.46
- Div yield
- 4.21%
More statistics
- Low
- 13.24
- High
- 13.30
- Forward P/E
- 0.00
- Beta
- 0.28
- Short ratio
- 0.81
- Inst. own
- 16.67%
- Dividend
- 0.55
- Ex-div date
- Jun 13, 2024
- 50-d avg
- 13.51
- 200-d avg
- 13.43
- 1y target
- 0.00
News
4 weeks ago marketbeat.com
Immix Biopharma Reports 89% Complete Response in NXC-201 AL Amyloidosis Study
Immix Biopharma NASDAQ: IMMX reported updated clinical data for NXC-201, its investigational CAR T-cell therapy for relapsed or refractory light-chain (AL) amyloidosis, and outlined plans for a…
9 months ago globenewswire.com
Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201
– Breakthrough Therapy Designation granted to NXC-201 based on positive NEXICART-2 Phase 2 interim clinical results, presented at the American Society of Hematology (ASH) 2025 annual meeting –
9 months ago businesswire.com
Nuveen Select Tax-Free Income Portfolios Announce Completion of Reorganizations
CHICAGO--(BUSINESS WIRE)--The reorganizations of Nuveen California Select Tax-Free Income Portfolio (NYSE: NXC) and Nuveen New York Select Tax-Free Income Portfolio (NYSE: NXN) into Nuveen Select…
10 months ago businesswire.com
Nuveen Closed-End Funds Announce Update to Reorganization Distributions
CHICAGO--(BUSINESS WIRE)--As previously announced, shareholders of the Nuveen Select Tax-Free Income Portfolio (NYSE: NXP), Nuveen California Select Tax-Free Income Portfolio (NYSE: NXC), and Nuveen…
10 months ago businesswire.com
Nuveen Select Tax-Free Income Portfolios Announce Shareholder Approval of Reorganization
CHICAGO--(BUSINESS WIRE)--Shareholders of the Nuveen Select Tax-Free Income Portfolio (NYSE: NXP), Nuveen California Select Tax-Free Income Portfolio (NYSE: NXC), and Nuveen New York Select Tax-Free…
11 months ago globenewswire.com
Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch
- Former Chimerix (CMRX, acquired by Jazz for $935 million) Senior Commercial Leader Michael Grabow led Go-To-Market Strategy and Launch for rare disease therapeutic MODEYSO® -
12 months ago globenewswire.com
Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025
- Oral presentation Sunday, December 7, at ASH 2025 - LOS ANGELES, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in…
1 year ago seekingalpha.com
Nuveen Wants To Merge NXC And NXN Into NXP: What Now?
I voted against the NXC and NXN merger into Nuveen Select Tax-Free Income Portfolio, as it would overweight NXP with bonds from states facing population decline and high taxes. NXP offers lower fees,…
1 year ago globenewswire.com
Immix Biopharma Announces Primary Endpoint Met in positive NXC-201 Interim Results Presented at ASCO, Enabling Path to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
Immix Biopharma today presented results at ASCO from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201, meeting its primary endpoint.
1 year ago globenewswire.com
Immix Biopharma Announces Positive Results for NXC-201 at ASCO Oral Presentation, Enabling Pathway to Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
Immix Biopharma today reported ASCO abstract results from its U.S. multi-center NEXICART-2 Phase 1/2 clinical trial of NXC-201 demonstrating strong efficacy and favorable safety.
1 year ago globenewswire.com
Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Data Selected for Oral Presentation at ASCO 2025
— Oral presentation Tuesday, June 3, 2025 in Chicago — LOS ANGELES, April 23, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage…
1 year ago seekingalpha.com
Sell Equities, Buy Municipal Debt At A 7.21% Discount With Nuveen California Select Tax-Free Income Portfolio
Municipal CEFs like Nuveen California Select Tax-Free Income Portfolio offer tax-free returns, low leverage, and are currently trading at a discount. NXC invests in high-quality municipal securities,…
1 year ago globenewswire.com
Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloidosis
FDA RMAT designation follows positive proof-of-concept U.S. clinical data from the NXC-201 NEXICART-2 clinical trial in relapsed/refractory AL Amyloidosis RMAT designation potentially streamlines the…
1 year ago globenewswire.com
Immix Biopharma Accelerates Enrollment in U.S. AL Amyloidosis Trial of NXC-201 CAR-T
LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”, “IMMX”), a clinical-stage biopharmaceutical company developing cell therapies…
1 year ago globenewswire.com
Journal of Clinical Oncology Publishes NXC-201 Positive Clinical Results in relapsed/refractory AL Amyloidosis
Chimeric antigen receptor T-cell (CAR-T) cell therapy NXC-201 is a novel approach to treat relapsed/refractory AL Amyloidosis NXC-201 demonstrated compelling clinical activity, rapid and deep…
2 years ago businesswire.com
Nuveen Closed-End Funds Declare Distributions and Updates to Distribution Policies
NEW YORK--(BUSINESS WIRE)--Nuveen Closed-End Funds today announced that the Board of Trustees of the Funds has approved the regular monthly and quarterly distributions. In addition, the Board of…
3 years ago seekingalpha.com
Weekly Closed-End Fund Roundup: January 8, 2023
21 out of 22 CEF sectors were positive on price and 20 out of 22 sectors were positive on NAV last week. MLPs are the most discounted CEF sector.
3 years ago seekingalpha.com
Weekly Closed-End Fund Roundup: VFL Tender Results (December 18, 2022)
2 out of 23 CEF sectors were positive on price and 2 out of 23 sectors were positive on NAV last week. VFL offers tender results.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 413 companies reached new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 329 companies hit new 52-week lows.
6 years ago seekingalpha.com
Weekly Closed-End Fund Roundup: June 21, 2020
4 out of 23 CEF sectors positive on price and 6 out of 23 sectors positive on NAV last week. MLPs lead while commodities lag. Preferreds have the highest sector
6 years ago seekingalpha.com
The Reopening Killed The V-Shaped Recovery
This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ
-
6 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Wednesday
-
6 years ago benzinga.com
14 Financial Services Stocks Moving In Monday's Session
14 Financial Services Stocks Moving In Monday's Session
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 9th
Stocks Which Set New 52-Week Low Yesterday, October 9th